Gabarol CR 82.5 mg (Tablet (Controlled Release))
Unit Price: ৳ 25.00 (3 x 10: ৳ 750.00)
Strip Price: ৳ 250.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Pregabalin |
| Company | Aci limited |
| Also available as |
Title
- Gabarol CR 82.5 mg Tablet
Categories
- Pain Management
- Neuropathic Pain Relief
- Seizure Management
Indications
- Diabetic Peripheral Neuropathy (DPN)
- Postherpetic Neuralgia (PHN)
- Adjunctive Therapy for Partial-Onset Seizures
- Fibromyalgia
- Neuropathic Pain Associated with Spinal Cord Injury
Pharmacology
- Structural Derivative of Gamma-Aminobutyric Acid (GABA)
- Binds to Alpha2-Delta Site in Central Nervous System Tissues
- Anti-Nociceptive and Antiseizure Effects
Dosage
- Maximum Recommended Dose of 100 mg three times a day for DPN
- Recommended Dose of 75 to 150 mg two times a day for PHN
- Recommended Dose of 300 to 450 mg/day for Fibromyalgia
- Recommended Dose Range of 150 to 600 mg/day for Spinal Cord Injury
Administration
- Oral Route
- Can be Taken with or Without Food
- CR Tablet to be Administered after Evening Meal
- Swallowed Whole, Not to be Split, Crushed, or Chewed
- Gradual Tapering when Discontinuing
Drug Interaction
- Unlikely to Involve Significant Pharmacokinetic Interactions
- No Significant Interactions with Food
Contraindications
- Hypersensitivity to Pregabalin or any of its Components
Side Effects
- Common Side Effects in Adults: Dizziness, Somnolence, Dry Mouth, Edema, Blurred Vision, Weight Gain, Difficulty with Concentration/Attention
- Common Side Effects in Pediatric Patients: Increased Weight, Increased Appetite
Pregnancy & Lactation
- No Well-Controlled Studies in Pregnant Women
- Small Amounts Detected in Lactating Women's Milk
- Breastfeeding Not Recommended due to Potential Risk of Tumorigenicity
Precautions & Warnings
- Angioedema as Potential Side Effect
- Risk of Suicidal Thoughts or Behavior
- Respiratory Depression
- May Cause Dizziness and Somnolence
- Increased Seizure Frequency upon Rapid Discontinuation
- Risk of Peripheral Edema
- Caution in Coadministration with Thiazolidinedione Antidiabetic Agents
Pediatric Uses
- Safety and Effectiveness not Established for Various Conditions in Pediatric Patients
Overdose Effects
- Signs and Symptoms include Reduced Consciousness, Depression/Anxiety, Seizures, Heart Block
- No Specific Antidote
- General Supportive Care Indicated
Therapeutic Class
- Adjunct Anti-Epileptic Drugs
- Primary Anti-Epileptic Drugs
Storage Conditions
- Keep in Cool & Dry Place (Below 30°C)
- Protected from Light & Moisture
- Keep out of Reach of Children
Chemical Structure
- Molecular Formula: C8H17NO2
- Chemical Structure Image Provided
Commonly Asked Questions
- Description of Gabarol CR 82.5 mg Tablet
- Frequency of Use
- Administration with Food
- Storage and Disposal Instructions
- Variation in Action for Different Diseases
- Duration of Use and Importance of Continuing Even if Feeling Fine
- Possible Concurrent Use with Diazepam
- Potential Weight Gain as Side Effect
- Quick Tips for Usage
Interaction with Medication
Unlikely to be involved in pharmacokinetic drug interactions
Interaction with Food
Not applicable
Management of Fibromyalgia
Recommended dose of 300 to 450 mg/day
Route of Administration
Oral route, CR tablet to be administered after evening meal
Storage and Disposal Instructions
Keep in a cool dry place and in its original packaging. Ensure it remains unreachable to children and pets